首页> 外文期刊>Journal of Surgical Oncology >Irradiation-induced up-regulation of Fas in esophageal squamous cell carcinoma is not accompanied by Fas ligand-mediated apoptosis.
【24h】

Irradiation-induced up-regulation of Fas in esophageal squamous cell carcinoma is not accompanied by Fas ligand-mediated apoptosis.

机译:辐射诱导的食管鳞状细胞癌Fas上调并不伴随Fas配体介导的细胞凋亡。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

BACKGROUND AND OBJECTIVES: Fas (APO-1) induces apoptosis after binding Fas ligand (FasL). Evidence suggests that tumors may use this interaction to evade the host immune response. Fas/FasL expression has not been reported in esophageal cancer. We hypothesized that Fas expression would render esophageal cancer cells susceptible to Fas ligation and that irradiation of the cells would increase Fas expression. METHODS: Two human esophageal squamous cell carcinoma lines, KYSE 150, which has a wild-type (wt) p53 gene, and 410 (mutated p53), were irradiated. Reverse-transcriptase polymerase chain reaction was used to detect Fas and FasL expression. Fas protein was quantitated by enzyme-linked immunosorbent assay and its presence further confirmed by Western analysis. FasL was detected by Western analysis. Cells were treated with Fas monoclonal antibody (maximum 0.05 microg/ml)+/-cycloheximide, and viability was assessed by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. Cells were also transduced with FasL cDNA and then quantified. RESULTS: Both lines expressed Fas and FasL, but only the KYSE 150 cell line displayed an increase in Fas following irradiation. No alteration in cell growth was detected for Fas antibody- or FasL-transduced groups versus controls. CONCLUSIONS: We have demonstrated Fas and FasL expression in esophageal tumor lines. We have also shown that Fas levels are significantly increased in response to irradiation in a wt p53 line. However, cells were resistant to treatment with Fas antibody or following transduction with FasL, suggesting that these tumor cells may use Fas/FasL expression to evade the host immune response.
机译:背景与目的:Fas(APO-1)结合Fas配体(FasL)后诱导凋亡。有证据表明,肿瘤可能利用这种相互作用逃避了宿主的免疫反应。食管癌中尚无Fas / FasL表达的报道。我们假设Fas的表达会使食管癌细胞容易被Fas结扎,而放射线照射会增加Fas的表达。方法:辐照两个人类食道鳞状细胞癌系,KYSE 150,其具有野生型(wt)p53基因,和410(突变的p53)。逆转录酶聚合酶链反应用于检测Fas和FasL表达。 Fas蛋白通过酶联免疫吸附测定进行定量,并通过Western分析进一步证实其存在。通过西方分析检测到FasL。用Fas单克隆抗体(最大0.05微克/毫升)+/-环己酰亚胺处理细胞,并通过3-(4,5-二甲基噻唑-2-基)-2,5-二苯基四唑溴化物(MTT)分析评估生存力。还用FasL cDNA转导细胞,然后进行定量。结果:两条细胞系均表达Fas和FasL,但只有KYSE 150细胞系在辐照后显示Fas增加。与对照相比,对于Fas抗体或FasL转导的组,未检测到细胞生长的变化。结论:我们已经证明了食管肿瘤细胞系中的Fas和FasL表达。我们还表明,响应wt p53品系中的辐照,Fas水平显着增加。然而,细胞对用Fas抗体治疗或在FasL转导后具有抗性,表明这些肿瘤细胞可能利用Fas / FasL表达来逃避宿主的免疫反应。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号